Top Markets
Coin of the day
Dogwood Therapeutics, Inc. Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc.

DWTX
Classifica tra le azioni #35719
Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to... Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions provoked by viral infections. Its leading therapeutic candidate, IMC-1, is a precise fixed-dose combination of famciclovir and celecoxib, engineered to combat fibromyalgia. Additionally, the company is advancing IMC-2, which blends valacyclovir and celecoxib, aiming to alleviate the array of symptoms linked to long COVID, including persistent fatigue, sleep disturbances, cognitive issues, pain, autonomic dysfunction, and anxiety. Previously operating as Virios Therapeutics, Inc., the organization adopted the name Dogwood Therapeutics, Inc. in October 2024. Established in 2012, the company maintains its main office in Alpharetta, Georgia.
Prezzo delle azioni
$1.84
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$3.51M
Variazione (1 giorno)
0.46%
Variazione (1 anno)
-62.71%
Paese
US
Scambia Dogwood Therapeutics, Inc. (DWTX)

Categoria

Cronologia dei frazionamenti azionari per Dogwood Therapeutics, Inc. (DWTX)
L’azione Dogwood Therapeutics, Inc. (simbolo: DWTX) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 16, 2026.
Una quota di DWTX acquistata prima di Aug 16, 2026 equivale oggi a 0 quote di DWTX.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE